共 50 条
- [2] ORAL-CONTRACEPTIVE USE MODIFIES THE MANIFESTATIONS OF PELVIC INFLAMMATORY DISEASE [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1986, 93 (06): : 619 - 624
- [3] ORAL-CONTRACEPTIVE USE AND THE RISK OF INFLAMMATORY BOWEL-DISEASE [J]. EPIDEMIOLOGY, 1992, 3 (04) : 374 - 378
- [4] DECREASED RISK OF SYMPTOMATIC CHLAMYDIAL PELVIC INFLAMMATORY DISEASE ASSOCIATED WITH ORAL-CONTRACEPTIVE USE [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (01): : 54 - 59
- [5] FACTORS ASSOCIATED WITH ORAL-CONTRACEPTIVE USE [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1980, 70 (10) : 1105 - 1108
- [6] BENIGN BREAST DISEASE AND ORAL-CONTRACEPTIVE USE [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (20): : 2199 - 2201
- [7] CIRCULATORY DISEASE IN ASSOCIATION WITH ORAL-CONTRACEPTIVE USE [J]. LANCET, 1979, 2 (8141): : 521 - 521
- [8] INFLAMMATORY BOWEL-DISEASE IN ORAL-CONTRACEPTIVE USERS [J]. GASTROENTEROLOGY, 1986, 91 (02) : 523 - 524
- [10] CHRONIC INTESTINAL ISCHEMIA ASSOCIATED WITH ORAL-CONTRACEPTIVE USE [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1982, 77 (01): : 32 - 34